Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Adv Drug Deliv Rev ; 188: 114457, 2022 09.
Artículo en Inglés | MEDLINE | ID: mdl-35843507

RESUMEN

Since the successful introduction of exogenous photosensitive proteins, channelrhodopsin, to neurons, optogenetics has enabled substantial understanding of profound brain function by selectively manipulating neural circuits. In an optogenetic system, optical stimulation can be precisely delivered to brain tissue to achieve regulation of cellular electrical activity with unprecedented spatio-temporal resolution in living organisms. In recent years, the development of various optical actuators and novel light-delivery techniques has greatly expanded the scope of optogenetics, enabling the control of other signal pathways in non-neuronal cells for different biomedical applications, such as phototherapy and immunotherapy. This review focuses on the recent advances in optogenetic regulation of cellular activities for photomedicine. We discuss emerging optogenetic tools and light-delivery platforms, along with a survey of optogenetic execution in mammalian and microbial cells.


Asunto(s)
Encéfalo/fisiología , Mamíferos/fisiología , Neuronas , Optogenética/tendencias , Animales , Channelrhodopsins/metabolismo , Humanos , Microbiota/fisiología , Neuronas/metabolismo , Optogenética/métodos , Fototerapia/tendencias , Transducción de Señal
2.
Med Sci (Paris) ; 36(11): 1038-1044, 2020 Nov.
Artículo en Francés | MEDLINE | ID: mdl-33151850

RESUMEN

Visual prostheses aim at restoring useful vision to patients who have become blind. This useful vision should enable them to regain autonomy in society for navigation, face recognition or reading. Two retinal prostheses have already obtained market authorization for patients affected by retinal dystrophies while a new device is in clinical trials for patients affected by age-related macular degeneration. Various prostheses, in particular cortical prostheses, are currently in clinical trials for optic neuropathies (glaucoma). Optogenetic therapy, an alternative strategy, has now reached the stage of clinical trials at the retinal level while moving forward at the cortical level. Other innovating strategies have obtained proofs of concepts in rodents but require a further validation in large animals prior to their evaluation on patients. Restoring vision should therefore become a reality for many patients even if this vision will not be as extensive and perfect as natural vision.


TITLE: Restauration de la vision: Science-fiction ou réalité ? ABSTRACT: Les prothèses visuelles ont pour objet de redonner une vision utile aux patients devenus aveugles. Cette vision utile doit leur permettre de retrouver une autonomie dans la société pour leurs déplacements, la reconnaissance des visages ou la lecture. Plusieurs prothèses rétiniennes ont déjà obtenu l'autorisation de mise sur le marché pour les dystrophies rétiniennes alors qu'un nouveau dispositif est en essai clinique pour la dégénérescence maculaire liée à l'âge. D'autres prothèses, notamment corticales, sont en essai clinique pour les neuropathies optiques (glaucome). Des stratégies alternatives, comme la thérapie optogénétique, ont également atteint le stade des essais cliniques. D'autres ont été évaluées sur les rongeurs, attendant leur validation sur le gros animal. Revoir devrait donc prochainement devenir une réalité pour de nombreux patients, même si cette vision ne sera ni aussi étendue, ni aussi parfaite que la vision naturelle.


Asunto(s)
Trastornos de la Visión/rehabilitación , Visión Ocular/fisiología , Prótesis Visuales , Animales , Humanos , Invenciones/tendencias , Magnetoterapia/instrumentación , Magnetoterapia/métodos , Magnetoterapia/tendencias , Nervio Óptico/patología , Nervio Óptico/fisiología , Optogenética/instrumentación , Optogenética/métodos , Optogenética/tendencias , Diseño de Prótesis , Regeneración/fisiología , Degeneración Retiniana/terapia , Trastornos de la Visión/terapia , Prótesis Visuales/química , Prótesis Visuales/clasificación , Prótesis Visuales/tendencias
3.
Brain Behav Immun ; 65: 1-8, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27890661

RESUMEN

The interactions between the brain and the immune system are bidirectional. Nevertheless, we have far greater understanding of how the immune system affects the brain than how the brain affects immunity. New technological developments such as optogenetics and chemogenetics (using DREADDs; Designer Receptors Exclusively Activated by Designer Drugs) can bridge this gap in our understanding, as they enable an unprecedented mechanistic and systemic analysis of the communication between the brain and the immune system. In this review, we discuss new experimental approaches for revealing neuronal circuits that can participate in regulation of immunity. In addition, we discuss methods, specifically optogenetics and chemogenetics, that enable targeted neuronal manipulation to reveal how different brain regions affect immunity. We describe how these techniques can be used as an experimental platform to address fundamental questions in psychoneuroimmunology and to understand how neuronal circuits associate with different psychological states can affect physiology.


Asunto(s)
Encéfalo/inmunología , Drogas de Diseño/farmacología , Optogenética/tendencias , Animales , Encéfalo/fisiología , Drogas de Diseño/síntesis química , Humanos , Neuronas/fisiología , Proyectos de Investigación , Transducción de Señal , Sistema Nervioso Simpático/inmunología , Sistema Nervioso Simpático/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA